Voltage-Gated Sodium Channel Blockers
"Voltage-Gated Sodium Channel Blockers" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of drugs that inhibit the activation of VOLTAGE-GATED SODIUM CHANNELS.
| Descriptor ID |
D061567
|
| MeSH Number(s) |
D27.505.519.562.750.500 D27.505.954.411.720.500
|
| Concept/Terms |
Voltage-Gated Sodium Channel Blockers- Voltage-Gated Sodium Channel Blockers
- Voltage Gated Sodium Channel Blockers
- Voltage-Gated Sodium Channel Inhibitors
- Voltage Gated Sodium Channel Inhibitors
- Channel Blockers, Voltage-Gated Sodium
- Channel Blockers, Voltage Gated Sodium
- Voltage-Gated Sodium Channel Antagonists
- Voltage Gated Sodium Channel Antagonists
|
Below are MeSH descriptors whose meaning is more general than "Voltage-Gated Sodium Channel Blockers".
Below are MeSH descriptors whose meaning is more specific than "Voltage-Gated Sodium Channel Blockers".
This graph shows the total number of publications written about "Voltage-Gated Sodium Channel Blockers" by people in this website by year, and whether "Voltage-Gated Sodium Channel Blockers" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Voltage-Gated Sodium Channel Blockers" by people in Profiles.
-
Walker A, Rupal A, Jani C, Al Omari O, Singh H, Patel D, Perrino C, McCannon J. Longstanding Phenytoin Use as a Cause of Progressive Dyspnea. Chest. 2022 02; 161(2):e91-e96.
-
Weiss MD, Macklin EA, Simmons Z, Knox AS, Greenblatt DJ, Atassi N, Graves M, Parziale N, Salameh JS, Quinn C, Brown RH, Distad JB, Trivedi J, Shefner JM, Barohn RJ, Pestronk A, Swenson A, Cudkowicz ME. A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progression. Neurology. 2016 Apr 19; 86(16):1474-81.
-
Fritz E, Izaurieta P, Weiss A, Mir FR, Rojas P, Gonzalez D, Rojas F, Brown RH, Madrid R, van Zundert B. Mutant SOD1-expressing astrocytes release toxic factors that trigger motoneuron death by inducing hyperexcitability. J Neurophysiol. 2013 Jun; 109(11):2803-14.